"The Saskatchewan Health Authority is the largest organization in Saskatchewan, employing over 40,000 employees and physicians responsible for the delivery of high quality and timely health care for the entire province of Saskatchewan. We are driven by the commitment to improve frontline patient care for Saskatchewan people, and we are working together to better coordinate health services across the province to ensure patients receive high quality, timely health care, wherever they live in Saskatchewan."

During the past decade, Saskatchewan Health Authority conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saskatchewan Health Authority" #1 collaborator was "University of Saskatchewan" with 3 trials as a collaborator, "Alberta Health services" with 1 trials as a collaborator, "Dalhousie University" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Institute for Clinical Evaluative Sciences" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Saskatchewan Health Authority" are "Abnormal Uterine Bleeding" (1 trials), "Bone Diseases, Metabolic" (1 trials), "Buprenorphine Dependence" (1 trials), "Co-infection" (1 trials) and "Dysmenorrhea" (1 trials). Many other conditions were trialed in "Saskatchewan Health Authority" in a lesser frequency.

Most popular intervention types in "Saskatchewan Health Authority" are "Drug" (3 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Biktarvy" (1 trials), "Epclusa" (1 trials), "Etonogestrel 68mg implant" (1 trials) and "Genvoya" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saskatchewan Health Authority" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Saskatchewan Health Authority". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Saskatchewan Health Authority, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saskatchewan Health Authority, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Saskatchewan Health Authority has several departments that took part in Clinical trials: "Jim Pattison Children's Hospital" - 16 trials, "Saskatchewan Transplant Program" - 2 trials